Heng Zhang

Heng Zhang

Auto-generated profile, based on publicly available information

Heng Zhang

Tianjin Medical University Cancer Institute and Hospital, State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, National Clinical Research Center for Cancer, Tianjin Institute of Immunology, Tianjin’s Clinical Research Center for Cancer, School of Basic Medical Sciences, Tianjin Medical University , Tianjin 300070

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2020 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
HZHeng Zhang
Heng Zhang
ZLZhuang Li
Zhuang Li
RXRenjian Xiao
Renjian Xiao
LCLeifu Chang
Leifu Chang

29 October 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
YLYi Lei
Yi Lei
QLQiangyun Liu
Qiangyun Liu
BCBinggui Chen
Binggui Chen
FWFangfang Wu
Fangfang Wu
YLYiming Li
Yiming Li
XWXiaohong Wang
Xiaohong Wang
Metabolic disorder significantly contributes to diabetic vascular complications, including diabetic retinopathy, the leading cause of blindness in the working-age population. However, the molecular mechanisms by which disturbed metabolic homeostasis causes vascular dysfunction in diabetic retinopathy remain unclear. O-GlcNAcylation modification acts as a nutrient sensor particularly sensitive to ambient glucose. Here, we observe pronounced O-GlcNAc elevation in retina endothelial cells of diabetic retinopathy patients and mouse models. Endothelial-specific depletion or pharmacological inhibition of O-GlcNAc transferase effectively mitigates vascular dysfunction. Mechanistically, we find that Yes-associated protein (YAP) and Transcriptional co-activator with PDZ-binding motif (TAZ), key effectors of the Hippo pathway, are O-GlcNAcylated in diabetic retinopathy. We identify threonine 383 as an O-GlcNAc site on YAP, which inhibits its phosphorylation at serine 397, leading to its stabilization and activation, thereby promoting vascular dysfunction by inducing a pro-angiogenic and glucose metabolic transcriptional program. This work emphasizes the critical role of the O-GlcNAc-Hippo axis in the pathogenesis of diabetic retinopathy and suggests its potential as a therapeutic target.

25 January 2021 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
ZLZhuang Li
Zhuang Li
HZHeng Zhang
Heng Zhang
RXRenjian Xiao
Renjian Xiao
RHRuijie Han
Ruijie Han
LCLeifu Chang
Leifu Chang

18 August 2022 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
XLXiao Liang
Xiao Liang
JXJun Xiao
Jun Xiao
XLXuzichao Li
Xuzichao Li
YLYujie Liu
Yujie Liu
YLYao Lu
Yao Lu
HZHeng Zhang
Heng Zhang

13 June 2023 in Cell Research
Verified
Journal Article
Open access
PDF file
XWXiaoshen Wang
Xiaoshen Wang
XLXuzichao Li
Xuzichao Li
GYGuimei Yu
Guimei Yu
LZLingling Zhang
Lingling Zhang
CZChendi Zhang
Chendi Zhang
HZHeng Zhang
Heng Zhang
Nicotinamide adenine dinucleotide (NAD+) is a central metabolite in cellular processes. Depletion of NAD+ has been demonstrated to be a prevalent theme in both prokaryotic and eukaryotic immune responses. Short prokaryotic Argonaute proteins (Agos) are associated with NADase domain-containing proteins (TIR-APAZ or SIR2-APAZ) encoded in the same operon. They confer immunity against mobile genetic elements, such as bacteriophages and plasmids, by inducing NAD+ depletion upon recognition of target nucleic acids. However, the molecular mechanisms underlying the activation of such prokaryotic NADase/Ago immune systems remain unknown. Here, we report multiple cryo-EM structures of NADase/Ago complexes from two distinct systems (TIR-APAZ/Ago and SIR2-APAZ/Ago). Target DNA binding triggers tetramerization of the TIR-APAZ/Ago complex by a cooperative self-assembly mechanism, while the heterodimeric SIR2-APAZ/Ago complex does not assemble into higher-order oligomers upon target DNA binding. However, the NADase activities of these two systems are unleashed via a similar closed-to-open transition of the catalytic pocket, albeit by different mechanisms. Furthermore, a functionally conserved sensor loop is employed to inspect the guide RNA–target DNA base pairing and facilitate the conformational rearrangement of Ago proteins required for the activation of these two systems. Overall, our study reveals the mechanistic diversity and similarity of Ago protein-associated NADase systems in prokaryotic immune response.

4 January 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
HYHang Yin
Hang Yin
JZJian Zheng
Jian Zheng
QHQiuqiu He
Qiuqiu He
XZXuan Zhang
Xuan Zhang
XLXuzichao Li
Xuzichao Li
HZHeng Zhang
Heng Zhang
The multifunctional GSDMB protein is an important molecule in human immunity. The pyroptotic and bactericidal activity of GSDMB is a host response to infection by the bacterial pathogen Shigella flexneri, which employs the virulence effector IpaH7.8 to ubiquitinate and target GSDMB for proteasome-dependent degradation. Furthermore, IpaH7.8 selectively targets human but not mouse GSDMD, suggesting a non-canonical mechanism of substrate selection. Here, we report the crystal structure of GSDMB in complex with IpaH7.8. Together with biochemical and functional studies, we identify the potential membrane engagement sites of GSDMB, revealing general and unique features of gasdermin proteins in membrane recognition. We further illuminate how IpaH7.8 interacts with GSDMB, and delineate the mechanism by which IpaH7.8 ubiquitinates and suppresses GSDMB. Notably, guided by our structural model, we demonstrate that two residues in the α1-α2 loop make the mouse GSDMD invulnerable to IpaH7.8-mediated degradation. These findings provide insights into the versatile functions of GSDMB, which could open new avenues for therapeutic interventions for diseases, including cancers and bacterial infections.